TLD (tenofovir disoproxil, lamivudine, dolutegravir)
Picture not included as there are many different versions.
This combination is only available in either low or middle-income countries. Or in some high-income countries where there are a high percentage of HIV positive people. This is because dolutegravir is still under patent in most high-income countries.
TLD is a single pill that should be taken every morning at roughly the same time. TLD can be taken with or without food.
It is one of the combinations with the lower risk of side effects. However, a small percentage of people (less than 1 in 20) have trouble sleeping (the reason to take it in the morning) or have mood changes.
The few drug interactions include:
- Not taking at the same time as multivitamin supplements that include calcium, magnesium or aluminium (see dolutegravir).
- Not taking with some non-steroidal anti-inflammatory drugs (NSAIDs) that are sold over the counter. For example: diclofenac, ibuprofen and naproxen (see tenofovir disoproxil).
There are many generic versions of tenofovir DF, lamivudine (3TC) and dolutegravir coformulated into a single pill (TLD). This is why we have not included a picture because this is manufactured by many different companies.
These include Acriptega, Dovimil, Emdolten, Lanograv, Lavern, Luvigen, Milutin, Nuvaco, Odystra, Ranega, Reydin, Telado, Telatri, Temiv, Tladeez, Viripil and Volutrip.
See this website that includes generics used in South Africa and other countries.
Widely used generic versions of TLD include:
|Commercial drug name||Generic manufacturer|
|Acriptega, Odystra, Ranega||Mylan Pharma|
|Dovimil, Luvigen, Milutin||Hetero Pharma|
|Lanograv, Telatri||Ranbaxy Drugs|
|Lavern, Temiv||Emcure Pharma|
|Reydin, Telado||Cipla Pharma|